Jiansheng Wu

SVP, Head of CRO Services October 2024 - Present VP, Head of Protein Sciences July 2021 - October 2024 • Lead multidisciplinary teams including antibody discovery, protein production and engineering, cell based assay, and in vivo pharmacology teams, totaling 500+ scientists. • Define and implement strategies for rapid and sustained revenue growth, doubling revenue in less than 3 years. • Build global project management, business development and marketing teams for CRO services. • Accelerate clients’ biologics drug development, ensuring a smooth transition from discovery to CMC. • Develop cutting-edge technologies for antibody discovery and protein production services • Innovate continuously to advance protein and antibody production services, establishing and maintaining industry leadership

Genentech, South San Francisco April 2006 - June 2021 Principle Scientific Manager II April 2021 - June 2021 Principle Scientific Manager July 2016 - March 2021 Senior Scientist January 2014 - June 2016 Scientist April 2006 - January 2014 • Participated in 50+ drug development projects across oncology, immunology, infectious disease and neurodegeneration. • Led multiple teams in the purification of proteins and antibodies. • Developed high-throughput purification platforms for monoclonal antibody and Fab fragments. • Established high-throughput protein purification platforms for His, GST, Flag and Fc-tagged proteins expressed in E.coli, insect, and mammalian systems. • Led protein outsourcing efforts supporting both large molecule (LM) and small molecule (SM) projects. • Built external protein production capacity at multiple CROs, including mammalian transient/stable expression and purification, and E.coli/BEVS expression and purification. • Oversaw 10+ internal FTE and 60+ external FTE for protein production

Sr. Scientist Protein Expression and Purification

Staff Scientist

Postdoc